Dosage regimen of an S1P receptor modulator
The present invention relates to a dosage regimen of an S1P receptor modulator or agonist in the course of the treatment of patients suffering from multiple sclerosis. Specifically, the present invention relates to testing a patient for a history of infection caused by varicella zoster virus and vaccinating the patient prior to administration of an S1P receptor modulator or agonist..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 19. Sept. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
BOULTON CRAIG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-09-19, Last update posted on www.tib.eu: 2023-10-11, Last updated: 2023-10-20 |
|---|
| Patentnummer: |
US11759436 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA01823562X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA01823562X | ||
| 003 | DE-627 | ||
| 005 | 20231020095134.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231013s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA01823562X | ||
| 035 | |a (EPA)US11759436 | ||
| 035 | |a (EPA)43759693 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a BOULTON CRAIG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dosage regimen of an S1P receptor modulator |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-09-19, Last update posted on www.tib.eu: 2023-10-11, Last updated: 2023-10-20 | ||
| 520 | |a The present invention relates to a dosage regimen of an S1P receptor modulator or agonist in the course of the treatment of patients suffering from multiple sclerosis. Specifically, the present invention relates to testing a patient for a history of infection caused by varicella zoster virus and vaccinating the patient prior to administration of an S1P receptor modulator or agonist. | ||
| 650 | 4 | |a che | |
| 650 | 4 | |a med | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61B: Diagnosis; surgery; identification (analysing biological material g01n, e.g. g01n0033480000) | |
| 650 | 4 | |a G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q) | |
| 650 | 4 | |a G16H: Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a BURTIN PASCALE |4 aut | |
| 700 | 0 | |a DAVID OLIVIER |4 aut | |
| 700 | 0 | |a DE VERA ANA |4 aut | |
| 700 | 0 | |a DUMORTIER THOMAS |4 aut | |
| 700 | 0 | |a HUNT IRENE |4 aut | |
| 700 | 0 | |a SCHMOUDER ROBERT |4 aut | |
| 700 | 0 | |a COLLINS WILLIAM C |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 19. Sept. |
| 773 | 1 | 8 | |g year:2023 |g day:19 |g month:09 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/43759693/publication/US11759436A1?q=US11759436 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 19 |c 09 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 19 |c 09 | ||